Angelo Corti
Angelo Corti
Professor of Biochemistry, Vita-Salute San Raffaele University, Milan, Italy
Verified email at
TitleCited byYear
Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure
R Ferrari, T Bachetti, R Confortini, C Opasich, O Febo, A Corti, G Cassani, ...
Circulation 92 (6), 1479-1486, 1995
The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases.
E Appella, EA Robinson, SJ Ullrich, MP Stoppelli, A Corti, G Cassani, ...
Journal of Biological Chemistry 262 (10), 4437-4440, 1987
Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes
MP Stoppelli, A Corti, A Soffientini, G Cassani, F Blasi, RK Assoian
Proceedings of the National Academy of Sciences 82 (15), 4939-4943, 1985
Enhancement of tumor necrosis factor α antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)
F Curnis, A Sacchi, L Borgna, F Magni, A Gasparri, A Corti
Nature biotechnology 18 (11), 1185-1190, 2000
Autocrine saturation of pro-urokinase receptors on human A431 cells
MP Stoppelli, C Tacchetti, MV Cubellis, A Corti, G Cassani, E Appella, ...
Cell 45 (5), 675-684, 1986
Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy
F Pastorino, C Brignole, D Marimpietri, M Cilli, C Gambini, D Ribatti, ...
Cancer research 63 (21), 7400-7409, 2003
Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells
F Curnis, G Arrigoni, A Sacchi, L Fischetti, W Arap, R Pasqualini, A Corti
Cancer research 62 (3), 867-874, 2002
Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration
F Curnis, A Sacchi, A Corti
The Journal of clinical investigation 110 (4), 475-482, 2002
Modulation of metastatic potential by cell surface urokinase of murine melanoma cells
VJ Hearing, LW Law, A Corti, E Appella, F Blasi
Cancer Research 48 (5), 1270-1278, 1988
Targeting liposomal chemotherapy via both tumor cell–specific and tumor vasculature–specific ligands potentiates therapeutic efficacy
F Pastorino, C Brignole, D Di Paolo, B Nico, A Pezzolo, D Marimpietri, ...
Cancer research 66 (20), 10073-10082, 2006
Chromogranin A in heart failure. A novel neurohumoral factor and a predictor for mortality
C Ceconi, R Ferrari, T Bachetti, C Opasich, M Volterrani, B Colombo, ...
European heart journal 23 (12), 967-974, 2002
The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties
KB Helle, A Corti, MH Metz-Boutigue, B Tota
Cellular and Molecular Life Sciences 64 (22), 2863-2886, 2007
Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif
G Colombo, F Curnis, GMS De Mori, A Gasparri, C Longoni, A Sacchi, ...
Journal of Biological Chemistry 277 (49), 47891-47897, 2002
Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function
M Pieroni, A Corti, B Tota, F Curnis, T Angelone, B Colombo, MC Cerra, ...
European heart journal 28 (9), 1117-1127, 2007
Spontaneous formation of L-isoaspartate and gain of function in fibronectin
F Curnis, R Longhi, L Crippa, A Cattaneo, E Dondossola, A Bachi, A Corti
Journal of Biological Chemistry 281 (47), 36466-36476, 2006
The neovasculature homing motif NGR: more than meets the eye
A Corti, F Curnis, W Arap, R Pasqualini
Blood, The Journal of the American Society of Hematology 112 (7), 2628-2635, 2008
Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A
K Lugardon, R Raffner, Y Goumon, A Corti, A Delmas, P Bulet, D Aunis, ...
Journal of biological chemistry 275 (15), 10745-10753, 2000
Coupling tumor necrosis factor-α with αV integrin ligands improves its antineoplastic activity
F Curnis, A Gasparri, A Sacchi, R Longhi, A Corti
Cancer Research 64 (2), 565-571, 2004
Synergistic antitumor activity of cisplatin, paclitaxel, and gemcitabine with tumor vasculature-targeted tumor necrosis factor-α
A Sacchi, A Gasparri, C Gallo-Stampino, S Toma, F Curnis, A Corti
Clinical Cancer Research 12 (1), 175-182, 2006
Oligomeric tumour necrosis factor α slowly converts into inactive forms at bioactive levels
A Corti, G Fassina, F Marcucci, E Barbanti, G Cassani
Biochemical Journal 284 (3), 905-910, 1992
The system can't perform the operation now. Try again later.
Articles 1–20